Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Repare Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-06-13
Purchase
2022-06-15
6:15 pm
Repare Therapeutics Inc. RPTX BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
149,161 $12.73 $1,898,820 412,604
(Direct)
View
2022-06-03
Sale
2022-06-07
4:37 pm
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
750,000 $12.25 $9,188,775 1,233,615
(Indirect
Direct)
View
2022-06-03
Sale
2022-06-07
4:36 pm
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
750,000 $12.25 $9,188,775 1,233,615
(Indirect
Direct)
View
2022-06-03
Sale
2022-06-07
4:32 pm
Repare Therapeutics Inc. RPTX Jerel Davis
Director
10% Owner
750,000 $12.25 $9,188,775 1,263,593
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
6:14 pm
Repare Therapeutics Inc. RPTX BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
1,836,958 $11.9 $21,859,329 406,436
(Direct)
View
2022-05-18
Purchase
2022-05-20
6:09 pm
Repare Therapeutics Inc. RPTX BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
420,000 $8.5 $3,570,000 313,357
(Direct)
View
2022-03-15
Sale
2022-03-16
4:04 pm
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
533 $11.3 $6,023 46,041
(Direct)
View
2022-01-19
Purchase
2022-01-21
5:12 pm
Repare Therapeutics Inc. RPTX BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
997,961 $14.1 $14,071,250 307,627
(Direct)
View
2021-11-16
Purchase
2021-11-18
5:00 pm
Repare Therapeutics Inc. RPTX Civik Thomas
Director
7,500 $28.08 $210,600 7,500
(Direct)
View
2021-11-15
Sale
2021-11-17
7:46 pm
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
20,000 $27.33 $546,613 533
(Direct)
View
2021-09-03
Sale
2021-09-08
6:29 pm
Repare Therapeutics Inc. RPTX Bonita David P
Director
8,084 $33.99 $274,794 96,190
(Indirect)
View
2021-09-03
Sale
2021-09-08
6:18 pm
Repare Therapeutics Inc. RPTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
8,084 $33.99 $274,794 96,190
(Indirect)
View
2021-08-31
Sale
2021-09-02
8:27 pm
Repare Therapeutics Inc. RPTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
37,864 $34.08 $1,290,550 96,428
(Indirect)
View
2021-08-31
Sale
2021-09-02
8:20 pm
Repare Therapeutics Inc. RPTX Bonita David P
Director
37,864 $34.08 $1,290,550 96,428
(Indirect)
View
2021-08-26
Sale
2021-08-30
6:37 pm
Repare Therapeutics Inc. RPTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
18,073 $34.07 $615,748 97,542
(Indirect)
View
2021-08-26
Sale
2021-08-30
6:33 pm
Repare Therapeutics Inc. RPTX Bonita David P
Director
18,073 $34.07 $615,748 97,542
(Indirect)
View
2021-08-23
Sale
2021-08-25
8:43 pm
Repare Therapeutics Inc. RPTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
18,215 $34.17 $622,426 98,074
(Indirect)
View
2021-08-23
Sale
2021-08-25
8:36 pm
Repare Therapeutics Inc. RPTX Bonita David P
Director
18,215 $34.17 $622,426 98,074
(Indirect)
View
2021-08-17
Sale
2021-08-25
8:25 pm
Repare Therapeutics Inc. RPTX Bonita David P
Director
20,328 $34.1 $693,210 98,610
(Indirect)
View
2021-08-16
Sale
2021-08-20
4:24 pm
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
15,000 $33.99 $509,886 20,533
(Direct)
View
2021-08-17
Sale
2021-08-19
8:55 pm
Repare Therapeutics Inc. RPTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
ORBIMED CAPITAL LLC
Director
20,328 $34.1 $693,210 98,610
(Indirect)
View
2021-08-17
Sale
2021-08-19
8:49 pm
Repare Therapeutics Inc. RPTX Bonita David P
Director
20,328 $34.1 $693,210 98,610
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-03
Other
2022-06-07
4:37 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
992,305 $0 1,233,615
(Indirect)
View
2022-06-03
Other
2022-06-07
4:36 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Ventures V LLC
Versant Ophthalmic Affiliates I L.P.
Versant Affiliates Fund V L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V GP-GP (Canada) Inc.
Versant Venture Capital V L.P.
Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Ventures V (Canada) L.P.
10% Owner
992,305 $0 1,233,615
(Indirect)
View
2022-06-03
Other
2022-06-07
4:32 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Jerel Davis
Director
10% Owner
1,001,406 $0 1,263,593
(Indirect)
View
2022-05-13
Option Award
2022-05-16
7:31 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX SCHAFER CAROL
Director
49,000 $0 49,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:30 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX Civik Thomas
Director
49,000 $0 49,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:29 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX RHOADS ANN D
Director
49,000 $0 49,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:27 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX Foley Todd
Director
49,000 $0 49,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:26 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX Jerel Davis
Director
49,000 $0 49,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:25 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX Morrison Briggs
Director
49,000 $0 49,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:24 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX Kulkarni Samarth
Director
49,000 $0 49,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
7:23 pm
N/A
2032-05-13
Repare Therapeutics Inc. RPTX Bonita David P
Director
49,000 $0 49,000
(Direct)
View
2022-01-21(A)
Exercise
2022-01-24
4:55 pm
N/A
2032-01-20
Repare Therapeutics Inc. RPTX Segal Lloyd Mitchell
CEO
300,000 $0 300,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:45 pm
N/A
2032-01-17
Repare Therapeutics Inc. RPTX Forte Steve
CFO
100,000 $0 100,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:43 pm
N/A
2032-01-17
Repare Therapeutics Inc. RPTX Koehler Maria
EVP Chief Medical Officer
115,000 $0 115,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:42 pm
N/A
2032-01-17
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
115,000 $0 115,000
(Direct)
View
2022-01-18
Exercise
2022-01-20
4:40 pm
N/A
2032-01-17
Repare Therapeutics Inc. RPTX Segal Lloyd Mitchell
CEO
300,000 $0 300,000
(Direct)
View
2021-12-10
Exercise
2021-12-10
4:43 pm
N/A
2029-05-01
Repare Therapeutics Inc. RPTX Koehler Maria
EVP Chief Medical Officer
48,511 $0 305,179
(Direct)
View
2021-12-10
Exercise
2021-12-10
4:43 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Koehler Maria
EVP Chief Medical Officer
48,460 $2.062 305,179
(Direct)
View
2021-12-10
Exercise
2021-12-10
4:43 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Koehler Maria
EVP Chief Medical Officer
51 $2.425 305,179
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
2027-06-14
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
46,041 $0 219,827
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
15,978 $1.637 219,827
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
19,590 $2.062 219,827
(Direct)
View
2021-11-23
Exercise
2021-12-06
4:47 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Zinda Michael
EVP Chief Science Officer
10,473 $2.425 219,827
(Direct)
View
2021-10-28
Ownership
2021-11-08
6:12 pm
N/A
N/A
Repare Therapeutics Inc. RPTX BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC
LAMPERT MARK N
10% Owner
0 $0 4,751,853
(Direct)
View
2021-09-07
Option Award
2021-09-09
5:06 pm
N/A
2031-09-07
Repare Therapeutics Inc. RPTX Civik Thomas
Director
42,000 $0 42,000
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, Next